FENTON MARY KAY (Chief Financial Officer) sold 3.4% of their position (4.40K shares) of CULLINAN THERAPEUTICS, INC. on the open market
Open‑market sale worth $59.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/23/2026ACC: 0001193125-26-064261
Officer· Chief Financial Officer
Since Feb 2026
-4.40K
Net shares
Net seller
$59.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.40K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.40K
Price / share
$13.62
Trade value
$59.90K
% of position
3.4%
2/20/2026
130.78K→126.38K
Total
Net shares
−4.40K
Net value
-$59.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2026 | S · Sale | −4.40K | $13.62 | $59.90K | 3.4% | 130.78K | 126.38K |
| Total | −4.40K | -$59.90K | ||||||
Derivative Transactions0
No derivative transactions reported